Crown Electrokinetics (NASDAQ:CRKN) gave fiscal Q1 and Q2 guidance, for Q1 Revenue is expected to be between $0.7M and $0.9M; Net Loss is anticipated to be between ($3.3)M and ($3.5)M.
For Q2 Revenue is expected to be between $7M and $8M; Net Income (Loss) is anticipated to be between ($0.5)M and $0.0M.
This guidance assumes, among other things, that no business acquisitions, restructurings, or legal settlements are concluded.
The stock price climbed 2% to $0.068 on Wednesday.